Last reviewed · How we verify
Volulyte
At a glance
| Generic name | Volulyte |
|---|---|
| Also known as | 6 % hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution |
| Sponsor | Brugmann University Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy
- Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications (PHASE4)
- Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery (PHASE4)
- Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery (PHASE4)
- Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection (PHASE4)
- Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients (PHASE4)
- Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid (PHASE3)
- Combination of Static Echocardiographic Indices for Prediction of Fluid Responsiveness During Cardiac Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |